289 related articles for article (PubMed ID: 33527139)
1. Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia.
Merke DP; Mallappa A; Arlt W; Brac de la Perriere A; Lindén Hirschberg A; Juul A; Newell-Price J; Perry CG; Prete A; Rees DA; Reisch N; Stikkelbroeck N; Touraine P; Maltby K; Treasure FP; Porter J; Ross RJ
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2063-e2077. PubMed ID: 33527139
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM; Stepien KM; Krishan A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012517. PubMed ID: 32190901
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.
Verma S; Vanryzin C; Sinaii N; Kim MS; Nieman LK; Ravindran S; Calis KA; Arlt W; Ross RJ; Merke DP
Clin Endocrinol (Oxf); 2010 Apr; 72(4):441-7. PubMed ID: 19486026
[TBL] [Abstract][Full Text] [Related]
4. Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.
Tschaidse L; Reisch N; Arlt W; Brac de la Perriere A; Linden Hirschberg A; Juul A; Mallappa A; Merke DP; Newell-Price JDC; Perry CG; Prete A; Rees DA; Stikkelbroeck NMML; Touraine PA; Coope H; Porter J; Ross RJM; Quinkler M
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36654495
[TBL] [Abstract][Full Text] [Related]
5. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
[TBL] [Abstract][Full Text] [Related]
6. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
Mallappa A; Sinaii N; Kumar P; Whitaker MJ; Daley LA; Digweed D; Eckland DJ; Van Ryzin C; Nieman LK; Arlt W; Ross RJ; Merke DP
J Clin Endocrinol Metab; 2015 Mar; 100(3):1137-45. PubMed ID: 25494662
[TBL] [Abstract][Full Text] [Related]
7. Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia.
Jones CM; Mallappa A; Reisch N; Nikolaou N; Krone N; Hughes BA; O'Neil DM; Whitaker MJ; Tomlinson JW; Storbeck KH; Merke DP; Ross RJ; Arlt W
J Clin Endocrinol Metab; 2017 Jun; 102(6):1797-1806. PubMed ID: 27845856
[TBL] [Abstract][Full Text] [Related]
8. Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.
Quinkler M; Miodini Nilsen R; Zopf K; Ventz M; Øksnes M
Eur J Endocrinol; 2015 May; 172(5):619-26. PubMed ID: 25656494
[TBL] [Abstract][Full Text] [Related]
9. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
Ahmed SEAM; Soliman AT; Ramadan MA; Elawwa A; Abugabal AMS; Emam MHA; De Sanctis V
Acta Biomed; 2019 Sep; 90(3):360-369. PubMed ID: 31580328
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
Neumann U; Braune K; Whitaker MJ; Wiegand S; Krude H; Porter J; Digweed D; Voet B; Ross RJM; Blankenstein O
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1433-e1440. PubMed ID: 32888021
[TBL] [Abstract][Full Text] [Related]
11. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Gröschl M; Rauh M; Dörr HG
J Clin Endocrinol Metab; 2002 Mar; 87(3):1200-4. PubMed ID: 11889188
[TBL] [Abstract][Full Text] [Related]
12. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
[TBL] [Abstract][Full Text] [Related]
13. Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia.
Mallappa A; Nella AA; Sinaii N; Rao H; Gounden V; Perritt AF; Kumar P; Ling A; Liu CY; Soldin SJ; Merke DP
Clin Endocrinol (Oxf); 2018 Oct; 89(4):399-407. PubMed ID: 30003563
[TBL] [Abstract][Full Text] [Related]
14. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.
Lawrence N; Bacila I; Dawson J; Bryce J; Ali SR; van den Akker ELT; Bachega TASS; Baronio F; Birkebaek NH; Bonfig W; van der Grinten HC; Costa EC; de Vries L; Elsedfy H; Güven A; Hannema S; Iotova V; van der Kamp HJ; Clemente M; Lichiardopol CR; Milenkovic T; Neumann U; Nordenström A; Poyrazoğlu Ş; Probst-Scheidegger U; De Sanctis L; Tadokoro-Cuccaro R; Thankamony A; Vieites A; Yavaş Z; Faisal Ahmed S; Krone N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):551-561. PubMed ID: 35781728
[TBL] [Abstract][Full Text] [Related]
15. Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency.
Bannon CAM; Border D; Hanson P; Hattersley J; Weickert MO; Grossman A; Randeva HS; Barber TM
Front Endocrinol (Lausanne); 2021; 12():641247. PubMed ID: 33776936
[TBL] [Abstract][Full Text] [Related]
16. Clinical advances in the pharmacotherapy of congenital adrenal hyperplasia.
Prete A; Auchus RJ; Ross RJ
Eur J Endocrinol; 2021 Nov; 186(1):R1-R14. PubMed ID: 34735372
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia.
Melin J; Parra-Guillen ZP; Michelet R; Truong T; Huisinga W; Hartung N; Hindmarsh P; Kloft C
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32052005
[TBL] [Abstract][Full Text] [Related]
18. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
19. Do All Patients with Congenital Adrenal Hyperplasia Need to Be on Hydrocortisone Three Times a Day in Order to Have Normal Growth?
Logan LA; Nebesio TD; Eckert GJ; Eugster EA
Horm Res Paediatr; 2022; 95(5):461-464. PubMed ID: 35649383
[TBL] [Abstract][Full Text] [Related]
20. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
